Back

Integrated multi-omics predictive analysis of atherosclerosis: a sub-study from the Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial

1 September 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Pharmacogenomics, cardio-omics, and cardiovascular drugs Aldosterone Antagonists ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Jean-Eudes Dazard

Case Western Reserve University, Cleveland (United States of America)

7 More presentations in this session

Presentation thumbnail
Potential use of pharmacogenetics in cardiology: genome-wide association studies of amiodarone-induced thyroid disorders
Mr S. Rand (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Pharmacogenomics of CRP response to statins: a GIST consortium study
Doctor E. Magavern (London, GB)
Abstract Slides Video
Presentation thumbnail
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation
Ms J. Brody (Seattle, US)
Abstract Slides Video
Presentation thumbnail
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis
Doctor M. Galli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Real-world implementation of a genotype-guided p2y12-inhibitor de-escalation strategy in acute coronary syndrome patients
Doctor J. Azzahhafi (Nieuwegein, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacogenomics, cardio-omics, and cardiovascular drugs

The Event

Event poster

ESC Congress 2024

1 September 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Multiomics and multimodal data integrations for prediction of cardiovascular events in atherosclerosis patients
29 August 2025
thumbnail
Congress Presentation
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
30 August 2024
thumbnail
Congress Presentation
HFWM: Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation
14 May 2024
thumbnail
Congress Presentation
The association of inflammation, triglycerides and lipoprotein(a) with cardiovascular events in the UK Biobank
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources